T. Beyer

发表

Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells.

P. Parren, T. Schneider-Merck, M. Peipp, 2008, Blood.

Recombinant Dimeric IgA Antibodies against the Epidermal Growth Factor Receptor Mediate Effective Tumor Cell Killing

S. Lohse, M. Peipp, J. Leusen, 2011, The Journal of Immunology.

and PMN effector cells Antibody fucosylation differentially impacts cytotoxicity mediated by NK

P. Parren, T. Schneider-Merck, M. Peipp, 2009 .

Complement-dependent tumor cell lysis triggered by combinations of epidermal growth factor receptor antibodies.

P. Parren, T. Schneider-Merck, M. Peipp, 2008, Cancer research.

This information is current as EGFR Kinase Mutations Are Not Affected by Lung Cancer-Associated Growth Factor Receptor (EGFR) Antibodies Tumor Cell Killing Mechanisms of Epidermal

P. Parren, T. Schneider-Merck, M. Peipp, 2013 .

Characterization of a Mutated IgA2 Antibody of the m(1) Allotype against the Epidermal Growth Factor Receptor for the Recruitment of Monocytes and Macrophages*

S. Lohse, M. Peipp, J. Leusen, 2012, The Journal of Biological Chemistry.

This information is current as Receptor Antibodies against Epidermal Growth Factor Effector Mechanisms of Recombinant IgA and

T. Schneider-Merck, M. Peipp, M. Dechant, 2007 .

Effector Mechanisms of Recombinant IgA Antibodies against Epidermal Growth Factor Receptor1

T. Schneider-Merck, M. Peipp, M. Dechant, 2007, The Journal of Immunology.

Impact of antibody Fc carbohydrate fucosylation on antibody-dependent cellular cytotoxicity by HuMax-EGFr -A fully human epidermal growth factor receptor antibody.

P. Parren, M. Peipp, J. J. Lammerts van Bueren, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mediate Effective Tumor Cell Killing the Epidermal Growth Factor Receptor Recombinant Dimeric IgA Antibodies against

S. Lohse, M. Peipp, J. Leusen, 2011 .

Antibody-Dependent Cellular Cytotoxicity Growth Factor Receptor Effectively Trigger Human IgG2 Antibodies against Epidermal

P. Parren, S. Lohse, T. Schneider-Merck, 2009 .

Antibody-Dependent Cellular Cytotoxicity Growth Factor Receptor Effectively Trigger Human IgG2 Antibodies against Epidermal

P. Parren, S. Lohse, T. Schneider-Merck, 2009 .

Expression of IgA Molecules in Mammalian Cells

S. Lohse, M. Dechant, T. Beyer, 2010 .

Serum-free production and purification of chimeric IgA antibodies.

S. Lohse, M. Peipp, M. Dechant, 2009, Journal of immunological methods.

Tumor Cell Killing Mechanisms of Epidermal Growth Factor Receptor (EGFR) Antibodies Are Not Affected by Lung Cancer-Associated EGFR Kinase Mutations

P. Parren, T. Schneider-Merck, M. Peipp, 2008, The Journal of Immunology.

Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2 m(1) antibody

S. Lohse, M. Peipp, J. Leusen, 2013, mAbs.

Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage

P. Parren, S. Lohse, T. Schneider-Merck, 2009, The Journal of Immunology.

Impact of Human IgA Antibodies on Complement-Dependent Cytotoxicity Mediated by Combinations of EGF-R-Directed Antibodies

S. Lohse, M. Peipp, M. Dechant, 2010, Archivum Immunologiae et Therapiae Experimentalis.

An optimized conditional suicide switch using doxycycline-dependent expression of human tBid

M. Hermann, W. Hillen, C. Berens, 2005, Cancer biology & therapy.